RECRUITINGINTERVENTIONAL

Cholesterol Self-testing in Patients Post Acute Coronary Syndrome

About This Trial

The pharmacological reduction of LDL-C lowers cardiovascular risk and is therefore a priority in cardiovascular secondary prevention. The achievement of LDL-C target levels in Germany, Europe, and worldwide is inadequate, despite a wide array of lipid-lowering medications. Only a small proportion of post-myocardial infarction patients reach their LDL-C target range within a year. There is a significant need for new strategies to improve LDL-C target achievement and thereby reduce the occurrence of secondary cardiovascular events. The aim of the study is to establish a basis for improving prevention by achieving the target LDL level effectively and quickly in patients with high and very high cardiovascular risk profiles.

Who May Be Eligible (Plain English)

Who May Qualify: - Age ≥ 18 years - Patients with acute coronary syndrome in the last 6 months and not having reached the LDL target value - Signed willing to sign a consent form Who Should NOT Join This Trial: - Persons unable to understand the study - Persons unable or unwilling to perform self-measurements - Persons unable or unwilling to undergo additional cholesterol-lowering therapy to reach the LDL target - Pre-menopausal women without contraception - Use of experimental drugs or investigational products within 30 days prior to screening - Employees or contractors of the institution conducting the study or family members of the Principal Investigator, Co-Investigator, or financial supporter Always talk to your doctor about whether this trial is right for you.

Original Eligibility Criteria

View original clinical language

Inclusion Criteria: * Age ≥ 18 years * Patients with acute coronary syndrome in the last 6 months and not having reached the LDL target value * Signed informed consent Exclusion Criteria: * Persons unable to understand the study * Persons unable or unwilling to perform self-measurements * Persons unable or unwilling to undergo additional cholesterol-lowering therapy to reach the LDL target * Pre-menopausal women without contraception * Use of experimental drugs or investigational products within 30 days prior to screening * Employees or contractors of the institution conducting the study or family members of the Principal Investigator, Co-Investigator, or financial supporter

Treatments Being Tested

OTHER

Cholesterol self-measurement

Patients will be trained to use a device to self-measurement of cholesterol-values monthly. After the measurement they will report their results to study team for ajusting the therapy.

Locations (1)

Clinic of cardiology University clinic Leipzig

Leipzig, Saxony, Germany